Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases. | Thorac Cancer | 2023 | 36977550 | PubTator, text mining | PubMed |
| Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea. | Curr Oncol | 2023 | 36975442 | PubTator, text mining | PubMed |
| Molecular Targets and Signaling Pathways in Cholangiocarcinoma: A Systematic Review. | Asian Pac J Cancer Prev | 2023 | 36974526 | PubTator, text mining | PubMed |
| Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer. | Front Oncol | 2023 | 36969062 | PubTator, text mining | PubMed |
| Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire. | Cancer Immunol Immunother | 2023 | 36943460 | PubTator, text mining | PubMed |
| Transcriptome responses of intestinal epithelial cells induced by membrane vesicles of Listeria monocytogenes. | Curr Res Microb Sci | 2023 | 36942003 | PubTator, text mining | PubMed |
| Characteristics of Renal Intravascular Large B-cell Lymphoma. | Kidney Int Rep | 2023 | 36938088 | PubTator, text mining | PubMed |
| A central chaperone-like role for 14-3-3 proteins in human cells. | Mol Cell | 2023 | 36931259 | PubTator, text mining | PubMed |
| RET signaling in breast cancer therapeutic resistance and metastasis. | Breast Cancer Res | 2023 | 36918928 | PubTator, text mining | PubMed |
| Adjusting Surface Models of Cellular Structures for Making Physical Models Using FDM Technology. | Polymers (Basel) | 2023 | 36904439 | PubTator, text mining | PubMed |
| Selected Predictors of COVID-19 Mortality in the Hospitalised Patient Population in a Single-Centre Study in Poland. | Healthcare (Basel) | 2023 | 36900724 | PubTator, text mining | PubMed |
| Performance Characteristics of Oncomine Focus Assay for Theranostic Analysis of Solid Tumors, A (21-Months) Real-Life Study. | Diagnostics (Basel) | 2023 | 36900081 | PubTator, text mining | PubMed |
| A deep graph convolutional neural network architecture for graph classification. | PLoS One | 2023 | 36897837 | PubTator, text mining | PubMed |
| Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence. | Endocr Relat Cancer | 2023 | 36877008 | PubTator, text mining | PubMed |
| Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma. | EBioMedicine | 2023 | 36868052 | PubTator, text mining | PubMed |
| A comprehensive overview of the relationship between RET gene and tumor occurrence. | Front Oncol | 2023 | 36865807 | PubTator, text mining | PubMed |
| Identification of key candidate genes and pathways in rheumatoid arthritis and osteoarthritis by integrated bioinformatical analysis. | Front Genet | 2023 | 36861127 | PubTator, text mining | PubMed |
| Integrated molecular and clinical analysis of BRAF-mutant glioma in adults. | NPJ Precis Oncol | 2023 | 36854806 | PubTator, text mining | PubMed |
| Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board. | Target Oncol | 2023 | 36853374 | PubTator, text mining | PubMed |
| Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial. | Nat Commun | 2023 | 36849516 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=15